| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0025-7753(00)71177-8 |
| P698 | PubMed publication ID | 10782458 |
| P2093 | author name string | I Anguera Camós | |
| P Brugada Terradellas | |||
| P2860 | cites work | Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study | Q70975003 |
| Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study | Q71020117 | ||
| Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation | Q71606989 | ||
| Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study | Q71721881 | ||
| Antithrombotic therapy in atrial fibrillation | Q71732669 | ||
| The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model | Q71782637 | ||
| Coronary heart disease and atrial fibrillation: the Framingham Study | Q71782665 | ||
| Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation | Q71950795 | ||
| Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration | Q71956990 | ||
| Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure | Q71964525 | ||
| Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study | Q72051686 | ||
| The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study | Q72198409 | ||
| Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation | Q72526986 | ||
| Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications | Q72566134 | ||
| Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation | Q72601348 | ||
| Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm | Q72623691 | ||
| Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities | Q72885801 | ||
| A focal source of atrial fibrillation treated by discrete radiofrequency ablation | Q73047603 | ||
| Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia | Q73151553 | ||
| Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system | Q73849466 | ||
| Atrioverter: an implantable device for the treatment of atrial fibrillation | Q77431175 | ||
| Sotalol, hypokalaemia, syncope, and torsade de pointes | Q28365910 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins | Q29620720 | ||
| Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation | Q33175535 | ||
| Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin | Q33610685 | ||
| Five-year experience with the maze procedure for atrial fibrillation | Q34343211 | ||
| Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study | Q36914538 | ||
| Interactions of warfarin with drugs and food | Q38571033 | ||
| Maintenance of sinus rhythm after atrial defibrillation | Q41363089 | ||
| Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation | Q41989836 | ||
| Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care | Q42221096 | ||
| Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine trial) | Q42277566 | ||
| Canadian atrial fibrillation anticoaguiation (CAFA) study | Q43928649 | ||
| Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy | Q44432066 | ||
| Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter | Q44675427 | ||
| Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. | Q45985183 | ||
| The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study | Q50542101 | ||
| Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. | Q50632243 | ||
| Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. | Q50969847 | ||
| Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. | Q51604516 | ||
| Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. | Q53578138 | ||
| The effects of atrial fibrillation on myocardial blood flow and energetics. | Q53840689 | ||
| Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. | Q54087868 | ||
| Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. | Q54114563 | ||
| Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. | Q54196432 | ||
| Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. | Q55054117 | ||
| Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation | Q57786465 | ||
| Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide | Q58819306 | ||
| Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension | Q58819310 | ||
| Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter | Q61965304 | ||
| Left atrial isolation associated with mitral valve operations | Q67591805 | ||
| Stroke Prevention in Atrial Fibrillation Study. Final results | Q67925848 | ||
| Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial | Q68037644 | ||
| Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry) | Q68092325 | ||
| Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm | Q68899284 | ||
| Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium | Q69258719 | ||
| The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation | Q69801094 | ||
| Risk of stroke in non-rheumatic atrial fibrillation | Q69894816 | ||
| Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation | Q69901331 | ||
| Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients | Q70212262 | ||
| Epidemiologic features of chronic atrial fibrillation: the Framingham study | Q70294399 | ||
| Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation | Q70343510 | ||
| Hemodynamic effects of cardioversion in chronic atrial fibrillation. Special reference to coronary artery disease | Q70348922 | ||
| Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi | Q70570906 | ||
| P433 | issue | 1 | |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 25-30 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Medicina clínica | Q26854009 |
| P1476 | title | [New perspectives in the nonpharmacological treatment of atrial fibrillation] | |
| P478 | volume | 114 |
| Q78304019 | [Splenic infarctions: an uncommon cause of fever] | cites work | P2860 |
Search more.